Market closed
Enfusion/$ENFN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. The products and services that comprise its solution are designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa.
Ticker
$ENFN
Sector
Trading on
NYSE
Industry
Software
Headquarters
Employees
1,143
Website
Enfusion Metrics
BasicAdvanced
$1B
358.67
$0.03
0.95
-
Price and volume
Market cap
$1B
Beta
0.95
52-week high
$11.80
52-week low
$7.83
Average daily volume
1.3M
Financial strength
Current ratio
3.421
Quick ratio
3.163
Long term debt to equity
14.302
Total debt to equity
20.406
Management effectiveness
Return on assets (TTM)
3.05%
Return on equity (TTM)
4.42%
Valuation
Price to earnings (TTM)
358.667
Price to revenue (TTM)
4.912
Price to book
13.91
Price to tangible book (TTM)
13.91
Price to free cash flow (TTM)
41.631
Growth
Revenue change (TTM)
15.51%
Earnings per share change (TTM)
-57.73%
3-year revenue growth (CAGR)
21.76%
3-year earnings per share growth (CAGR)
-76.27%
What the Analysts think about Enfusion
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Enfusion stock.
Enfusion Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Enfusion Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Enfusion News
AllArticlesVideos
Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration
Business Wire·2 weeks ago
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
Business Wire·2 weeks ago
Clearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Enfusion stock?
Enfusion (ENFN) has a market cap of $1B as of April 19, 2025.
What is the P/E ratio for Enfusion stock?
The price to earnings (P/E) ratio for Enfusion (ENFN) stock is 358.67 as of April 19, 2025.
Does Enfusion stock pay dividends?
No, Enfusion (ENFN) stock does not pay dividends to its shareholders as of April 19, 2025.
When is the next Enfusion dividend payment date?
Enfusion (ENFN) stock does not pay dividends to its shareholders.
What is the beta indicator for Enfusion?
Enfusion (ENFN) has a beta rating of 0.95. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.